Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 20 stocks, with a combined market cap of $3.14 trillion, total revenue of $698.61 billion and a weighted average PE ratio of 24.44.

Market Cap
3.14T
Revenue
698.61B
Profits
128.65B
PE Ratio
24.44
Profit Margin
18.41%
Dividend Yield
2.10%

20 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company696.55B-0.47%2,733,42049.00B
2JNJJohnson & Johnson375.15B2.08%10,889,12489.33B
3ABBVAbbVie Inc.335.60B2.35%5,937,41657.37B
4NVONovo Nordisk A/S306.99B1.16%6,851,62043.92B
5NVSNovartis AG242.04B1.73%1,430,40453.22B
6AZNAstraZeneca PLC221.11B2.26%6,730,24554.98B
7MRKMerck & Co., Inc.205.43B3.35%21,800,65163.92B
8AMGNAmgen Inc.156.21B4.05%3,468,98934.13B
9PFEPfizer Inc.142.36B3.30%59,258,79462.46B
10GILDGilead Sciences, Inc.138.98B0.78%7,677,11528.74B
11SNYSanofi119.13B1.53%1,602,90848.82B
12BMYBristol-Myers Squibb Company96.69B2.64%21,111,32547.64B
13GSKGSK plc78.34B1.43%6,831,48440.74B
14BIIBBiogen Inc.19.06B3.57%1,919,6299.82B
15GRFSGrifols, S.A.7.51B-0.39%246,9757.97B
16OGNOrganon & Co.2.61B3.82%5,504,6806.29B
17AMRNAmarin Corporation plc348.08M3.64%138,136214.11M
18MDCXMedicus Pharma Ltd.47.00M-1.34%147,679-
19SCLXScilex Holding Company33.18M2.55%60,18050.71M
20MIRAMIRA Pharmaceuticals, Inc.20.47M-125,381-